Drug maker GSK invests in gene profiling services

Drug maker GlaxoSmithKline says second-quarter revenue totaled 7.3 billion pounds ($9.6 billion), a 4 percent increase at constant currency exchange rates, amid promising performances for vaccines and a new shingles treatment

from ABC News: Health https://ift.tt/2LQd1ZB
via HEALTH